About this Research Topic
This research topic aims to explore the complex network of receptor signaling pathways that play a pivotal role in the development and progression of cancer. By understanding the intricate signal transduction mechanisms, we can identify key players in oncogenic pathways that may serve as potential targets for therapy. The focus will be on the latest advancements in the identification of biomarkers for early detection, strategies for disrupting aberrant signaling in cancer cells, cross-talk between receptors, specific mutation of receptors and the development of targeted therapies that can selectively inhibit these pathways. Contributions are invited that shed light on the molecular underpinnings of receptor-mediated communication within the tumor microenvironment and its impact on cancer metastasis and resistance to treatment. This topic seeks to provide a comprehensive overview of current challenges and innovative approaches in molecular oncology, with the ultimate goal of improving patient outcomes in the fight against cancer.
The central problem to be addressed in this Research Topic is the complexity of receptor signaling pathways in cancer and their role in tumorigenesis and resistance to therapy. Despite significant advancements, the intricate network of signaling remains a challenge due to its dynamic nature and the ability of cancer cells to adapt and resist treatment.
To address this problem, the following approaches can be undertaken:
-Comprehensive Mapping: Systematic mapping of receptor signaling networks in various cancer types to identify unique and common pathways that contribute to cancer progression.
-Technological Integration: Utilizing recent advances in single-cell sequencing, proteomics, and bioinformatics to dissect the heterogeneity of receptor signaling within tumors.
-Therapeutic Targeting: Development of novel targeted therapies that can selectively inhibit key nodes in the signaling network, informed by the mapping and technological studies.
-Biomarker Discovery: Identification of predictive biomarkers for responsiveness to targeted therapies through analysis of receptor signaling patterns.
-Clinical Trials: Designing and conducting clinical trials to test the efficacy of new targeted therapies, with a focus on overcoming resistance mechanisms.
-Interdisciplinary Collaboration: Encouraging collaboration between molecular biologists, clinicians, and computational scientists to translate findings from bench to bedside.
By focusing on these areas, we can hope to gain a deeper understanding of receptor signaling in cancer, leading to more effective and personalized treatment strategies. Recent advances in CRISPR technology, artificial intelligence in drug discovery, and the development of bi-specific antibodies are some of the cutting-edge tools that can propel this field forward.
The Research Topic on receptor signaling in cancer encompasses a broad spectrum of multidisciplinary studies aimed at elucidating the role of receptors in cancer biology, the intricacies of their signaling pathways, and the potential for therapeutic intervention. Authors are encouraged to submit original research, reviews, and methodological articles that contribute to our understanding of these complex mechanisms. This collection seeks to foster advancements in cancer treatment, making it an invaluable resource for researchers in the field.
The central problem to be addressed in this Research Topic is the complexity of receptor signaling pathways in cancer and their role in tumorigenesis and resistance to therapy. Despite significant advancements, the intricate network of signaling remains a challenge due to its dynamic nature and the ability of cancer cells to adapt and resist treatment.
To address this problem, the following approaches can be undertaken:
-Comprehensive Mapping: Systematic mapping of receptor signaling networks in various cancer types to identify unique and common pathways that contribute to cancer progression.
-Technological Integration: Utilizing recent advances in single-cell sequencing, proteomics, and bioinformatics to dissect the heterogeneity of receptor signaling within tumors.
-Therapeutic Targeting: Development of novel targeted therapies that can selectively inhibit key nodes in the signaling network, informed by the mapping and technological studies.
-Biomarker Discovery: Identification of predictive biomarkers for responsiveness to targeted therapies through analysis of receptor signaling patterns.
-Clinical Trials: Designing and conducting clinical trials to test the efficacy of new targeted therapies, with a focus on overcoming resistance mechanisms.
-Interdisciplinary Collaboration: Encouraging collaboration between molecular biologists, clinicians, and computational scientists to translate findings from bench to bedside.
By focusing on these areas, we can hope to gain a deeper understanding of receptor signaling in cancer, leading to more effective and personalized treatment strategies. Recent advances in CRISPR technology, artificial intelligence in drug discovery, and the development of bi-specific antibodies are some of the cutting-edge tools that can propel this field forward.
The Research Topic on receptor signaling in cancer encompasses a broad spectrum of multidisciplinary studies aimed at elucidating the role of receptors in cancer biology, the intricacies of their signaling pathways, and the potential for therapeutic intervention. Authors are encouraged to submit original research, reviews, and methodological articles that contribute to our understanding of these complex mechanisms. This collection seeks to foster advancements in cancer treatment, making it an invaluable resource for researchers in the field.
Keywords: Receptor signaling Cancer progression, Signal transduction, Oncogenic pathways, Targeted therapy, Biomarkers, Cell communication, GPCR Ligand-gated ion, Channel Nuclear receptors, Growth factors receptors
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
